Melasma, Vitiligo, Post Inflammatory hyperpigmentation, Lentigo are some of the common pigmentary disorders that has been of cosmetic concern to many. At CIDP, we propose various protocols to substantiate claims across these pathologies. Over the past 19 years, CIDP has conducted over 30 studies on melasma, a skin condition characterised by light to dark brown or brown-grey coloured patches with symmetrical distribution involving the central part of the face including forehead, cheeks, nose, and chin.
Studies involving the comparative efficacy of novel treatments (including hydroquinone) or therapies in improving skin pigmentation are conducted at CIDP under regulated norms.
Our highly trained dermatologists and experts can visually assess the intensity, size, and homogeneity of pigmentary areas through standardised scales (MASI, MSS, PAHPI, VAS). Furthermore, our recent investment, the new upgraded VISIA CR5 now allows for even better imaging to illustrative claims or for image analysis.
Explore Trends and Innovations at NYSCC To register, click here 📅 on Tuesday May…
Roger Guillemin identified the molecules in the brain that control the production of hormones in…
In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…